Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report

BACKGROUND: Myelin oligodendrocyte glycoprotein immunoglobulin G1 (MOG-IgG1)-associated disease is suggested as a separate disease entity distinct from multiple sclerosis and neuromyelitis optica spectrum disorder. Nonetheless, the optimal treatment regimen for preventing relapses in MOG-IgG1-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seok-Jin, Kim, Boram, Lee, Haeng-Jin, Kim, Seong-Joon, Kim, Sung-Min, Sung, Jung-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302456/
https://www.ncbi.nlm.nih.gov/pubmed/30577778
http://dx.doi.org/10.1186/s12883-018-1222-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302456/
https://www.ncbi.nlm.nih.gov/pubmed/30577778
http://dx.doi.org/10.1186/s12883-018-1222-1

Ejemplares similares